Solvay Picks Up Tricor Franchise Through Acquisition Of Fournier Pharma
Executive Summary
Solvay plans to continue working with Abbott on the Tricor franchise in the U.S. after acquiring Fournier Pharma
You may also be interested in...
Solvay Confirms It Is Looking At Options – But For All Of Its Businesses
In an interview, Solvay Pharma CEO says the company is “taking the offensive.”
Abbott Considering Tricor/Statin Combination On Heels Of Labeling Change
Abbott is considering developing a Tricor/statin combination product, Pharmaceutical Product Group President Jeffrey Leiden said Jan. 18
505(b)(2) Patent Certifications Attach To Reference Drug, Not Drug Substance
A 505(b)(2) NDA sponsor need only certify to patents for the reference listed drug product, not all patents associated with a drug substance, FDA said in rejecting an Abbott citizen petition regarding fenofibrate Nov. 30